ANTIPHOSPHOLIPID ANTIBODIES AS A CAUSE OF RENAL ALLOGRAFT LOSS. • 2174
نویسندگان
چکیده
منابع مشابه
Glomerular damage as a predictor of renal allograft loss.
Interstitial fibrosis and tubular atrophy (IF/TA) are the most common cause of renal graft failure. Chronic transplant glomerulopathy (CTG) is present in approximately 1.5-3.0% of all renal grafts. We retrospectively studied the contribution of CTG and recurrent post-transplant glomerulopathies (RGN) to graft loss. We analyzed 123 patients with chronic renal allograft dysfunction and divided th...
متن کاملAntiphospholipid antibodies and renal involvement.
Antiphospholipid antibodies are a heterogeneous group of autoantibodies associated with the hypercoagulable state affecting all vascular districts with thrombosis named antiphospholipid syndrome (APS). APS is an autoimmune disease with multifactorial etiology that includes cellular, molecular, genetic and pathogenic mechanisms. The APS clinical features are a combination of arterial and/or veno...
متن کاملAntiphospholipid antibodies among women experiencing fetal loss.
The presence of antiphospholipid antibodies (aPLs) is closely associated with thrombotic events and pregnancy complications such as recurrent pregnancy loss, preeclampsia and placental insufficiency. We investigated the presence of aPLs and its frequency among female patients with a history of fetal loss in a Malaysia population. Serum samples were collected from 108 patients who had (1) one or...
متن کاملAcute renal allograft thrombosis in ‘seronegative’ antiphospholipid syndrome
Acute renal allograft thrombosis in 'seronegative' antiphospholipid syndrome Sir, We present a 32-year-old Asian female with ESRD secondary to lupus nephritis who received a deceased donor kidney transplant but lost the graft 5 days later. Her medical history was significant for a pregnancy complicated by hy-pertension and intra-uterine growth retardation with absent end diastolic flow. This ne...
متن کامل“Out of Sight, Out of Mind”: The Failed Renal Allograft as a Cause of ESA Resistance
Approximately 10% of patients treated with erythropoiesis-stimulating agents (ESAs) for the anemia of chronic kidney disease are unresponsive or relatively resistant to therapy. The etiology of this is usually linked to iron deficiency or an independent underlying illness. We describe a hemodialysis patient with a failed renal transplant 1.5 years earlier, who developed progressive erythropoiet...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1996
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-199604001-02198